Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000372724

Medchemexpress LLC FHD-609 | 2676211-64-4 | C47H56N8O6 | 500 MG
SDP

Supplier:  Medchemexpress LLC HY153367500MG

Encompass_Preferred

FHD-609 is a PROTAC degrader and inhibitor of BRD9 (Bromodomain-containing protein 9), targeting ncBAF. It can be utilized for research into various cancers featuring mutations in a BAF complex subunit. This compound has demonstrated sustained BRD9 degradation and anti-tumor activities in preclinical models. In combination with Telomelysin or INO5401, FHD-609 may contribute to the treatment of adrenocortical carcinoma (ACC).

  • Targets ncBAF
  • Used for research into cancers with BAF complex subunit mutations
  • Exhibits anti-tumor activities in preclinical models
  • May be useful in adrenocortical carcinoma (ACC) treatment when combined with other agents

Catalog No. 50-003-72724


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.